New Norwegian guidelines recommend thiazide diuretics as first-line antihypertensive treatment.
This change is linked to a 2004 parliamentary resolution and the ALLHAT study.
The ALLHAT study involved elderly, high-risk patients, including a significant proportion of African Americans.
Purpose:
To evaluate the suitability of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack (ALLHAT) study findings for informing Norwegian antihypertensive treatment guidelines.
Summary:
The ALLHAT study, despite influencing Norwegian guidelines, has significant limitations in its design, results, analysis, and interpretation.
These shortcomings render the ALLHAT study unsuitable as a foundation for general antihypertensive treatment guidelines in Norway.
Impact:
Critiques the reliance on the ALLHAT study for national treatment guidelines.
Highlights the need for robust evidence in formulating public health policies for hypertension management.
Suggests re-evaluation of the basis for current Norwegian antihypertensive medication guidelines.